The drug “Odecromone®” became a nominee of the All-Russian open competition of pharmaceutical industry professionals “Platinum Ounce” in the nomination “Drug of the Year”, sub-nomination “Launch of the Year. Retail segment”.
The main active component of the drug “Odecromone®” is hymecromone. It has a unique combination of two therapeutic effects: selective antispasmodic and choleretic. This combination helps improve bile outflow, reducing bile stagnation in the gallbladder, prevents cholesterol crystallization and helps prevent the formation of gallstones. The drug is indicated for a number of diseases associated with dysfunction of the biliary tract. It also helps to normalize the functions of the gallbladder, improving the general well-being of the patient.
“Platinum Ounce” is one of the most authoritative professional competitions in the pharmaceutical industry of Russia, which annually brings together leading representatives of the industry, government agencies and the scientific community. The main idea of the competition is to create conditions for the formation of a pharmaceutical market that meets international standards for the quality of goods and services, as well as the development of mechanisms that will provide the population with effective and safe drugs.
